Clinical Trials/CTRI/2022/10/046686

CTRI/2022/10/046686

Not yet recruiting

未知

Clinical profile and multimodal imaging characteristics of Macular Telangiectasia Type 2 in Indian population

Aravind Eye Hospital Chennai0 sites0 target enrollmentTBD

Overview

Phase: 未知
Intervention: Not specified
Conditions: Not specified
Sponsor: Aravind Eye Hospital Chennai
Status: Not yet recruiting
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

3 years ago

Study Type

Observational

Investigators

Sponsor

Aravind Eye Hospital Chennai

Eligibility Criteria

Inclusion Criteria

•All consecutive patients with clinical suspicion of Macular Telangiectasia Type 2 above 30 years of age attending Aravind Eye Hospital Out Patient Department

Exclusion Criteria

•co\-existing macular pathology
•prior vitreoretina surgery
•severe media opacity precluding grading of image
•pregnant and lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials

The study is to assess the retinal biomarkers in patients diagnosed with macular telangiectasia.

CTRI/2018/03/012742Giridhar Eye Institute25

Multimodal Model Predicts RecurrenceGastric Adenocarcinoma

NCT06690268Qun Zhao93

The value of clinical factors, imaging features and biological characteristics for the prediction of outcome after radiotherapy in larynx cancer.

NL-OMON28459Maastro Clinic400

Multimodality Imaging and Functional Lesion Assessment in Intermediate Coronary Stenosis in Chronic Coronary SyndromeChronic Coronary Syndrome

NCT06261866Medical University of Warsaw200

Active, not recruiting

Phase 2a open label study of Fovista¿ (anti-PDGF agent) administered in combination with anti-VEGF therapy in subjects previously treated or treatment-naive.Subfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 20.0Level: PTClassification code 10071129Term: Neovascular age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.1Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]

EUCTR2015-000519-42-ITIVERIC bio, Inc.32